<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31936602</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>09</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>VAPB ER-Aggregates, A Possible New Biomarker in ALS Pathology.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">164</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells9010164</ELocationID><Abstract><AbstractText>A point mutation (P56S) in the gene-encoding vesicle-associated membrane-protein-associated protein B (VAPB) leads to an autosomal-dominant form of amyotrophic lateral sclerosis (ALS), classified as ALS-8. The mutant VAPB is characterized by ER-associated aggregates that lead to a complete reorganization of ER structures. Growing evidences suggest VAPB involvement in ALS pathomechanisms. In fact, numerous studies demonstrated VAPB alteration also in sporadic ALS (sALS) and showed the presence of its aggregates when others ALS-related gene are mutant. Recently, the identification of new biomarkers in peripheral blood mononuclear cells (PBMCs) has been proposed as a good noninvasive option for studying ALS. Here, we evaluated VAPB as a possible ALS pathologic marker analyzing PBMCs of sALS patients. Immunofluorescence analysis (IFA) showed a peculiar pattern of VAPB aggregates in sALS, not evident in healthy control (HC) subjects and in Parkinson's disease (PD) PBMCs. This specific pattern led us to suppose that VAPB could be misfolded in sALS. The data indirectly confirmed by flow cytometry assay (FCA) showed a reduction of VAPB fluorescent signals in sALS. However, our observations were not associated with the presence of a genetic mutation or altered gene expression of VAPB. Our study brings further evidences of the VAPB role in ALS as a diagnostic biomarker.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cadoni</LastName><ForeName>Maria Piera L</ForeName><Initials>MPL</Initials><Identifier Source="ORCID">0000-0002-8400-6201</Identifier><AffiliationInfo><Affiliation>Department of Medical Surgical and Experimental Sciences, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biggio</LastName><ForeName>Maria Luigia</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Medical Surgical and Experimental Sciences, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arru</LastName><ForeName>Giannina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Surgical and Experimental Sciences, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Secchi</LastName><ForeName>Giannina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Surgical and Experimental Sciences, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orr&#xf9;</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, S. P. Monserrato-Sestu km 0,700, 09042 Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clemente</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Medical Surgical and Experimental Sciences, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sechi</LastName><ForeName>GianPietro</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9515-0014</Identifier><AffiliationInfo><Affiliation>Department of Medical Surgical and Experimental Sciences, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamoah</LastName><ForeName>Alfred</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, RWTH Aachen University Medical School, Pauwelsstr. 30, 52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripathi</LastName><ForeName>Priyanka</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, RWTH Aachen University Medical School, Pauwelsstr. 30, 52074 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orr&#xf9;</LastName><ForeName>Sandro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, S. P. Monserrato-Sestu km 0,700, 09042 Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manetti</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medical Surgical and Experimental Sciences, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galleri</LastName><ForeName>Grazia</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5379-9387</Identifier><AffiliationInfo><Affiliation>Department of Medical Surgical and Experimental Sciences, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C496748">VAPB protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D033921">Vesicular Transport Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004721" MajorTopicYN="N">Endoplasmic Reticulum</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005453" MajorTopicYN="N">Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="Y">Protein Aggregates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033921" MajorTopicYN="N">Vesicular Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">PBMC</Keyword><Keyword MajorTopicYN="N">VAPB ER-aggregates</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">endoplasmic reticulum</Keyword><Keyword MajorTopicYN="N">flow cytometry</Keyword><Keyword MajorTopicYN="N">immunofluorescence</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31936602</ArticleId><ArticleId IdType="pmc">PMC7017080</ArticleId><ArticleId IdType="doi">10.3390/cells9010164</ArticleId><ArticleId IdType="pii">cells9010164</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pansarasa O., Rossi D., Berardinelli A., Cereda C. Amyotrophic lateral sclerosis and skeletal muscle: An update. Mol. Neurobiol. 2014;49:984&#x2013;990. doi: 10.1007/s12035-013-8578-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8578-4</ArticleId><ArticleId IdType="pubmed">24198230</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei S., Carr K., Reiley L., Diaz K., Guerra O., Altamirano P.F., Pagani W., Lodin D., Orozco G., Chinea A. A comprehensive review of amyotrophic lateral sclerosis. Surg. Neurol. Int. 2015;6:171. doi: 10.4103/2152-7806.169561.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pmc">PMC4653353</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S., Stauffer J.E., Schulte D.J., Ravits J. Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol. Clin. 2015;33:855&#x2013;876. doi: 10.1016/j.ncl.2015.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.012</ArticleId><ArticleId IdType="pmc">PMC4628785</ArticleId><ArticleId IdType="pubmed">26515626</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K., Nishimoto I., Aiso S., Matsuoka M. Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8) J. Biol. Chem. 2006;281:30223&#x2013;30233. doi: 10.1074/jbc.M605049200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M605049200</ArticleId><ArticleId IdType="pubmed">16891305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince P.G., Highley J.R., Kirby J., Wharton S.B., Takahashi H., Strong M.J., Shaw P.J. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: An emerging molecular pathway and the significance of glial pathology. Acta Neuropathol. 2011;122:657&#x2013;671. doi: 10.1007/s00401-011-0913-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0913-0</ArticleId><ArticleId IdType="pubmed">22105541</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S., Ando Y. Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis. Transl. Neurodegener. 2015;4:13. doi: 10.1186/s40035-015-0036-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-015-0036-y</ArticleId><ArticleId IdType="pmc">PMC4513711</ArticleId><ArticleId IdType="pubmed">26213621</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzoni V., Pansarasa O., Diamanti L., Nosari G., Cereda C., Ceroni M. Amyotrophic lateral sclerosis and environmental factors. Funct. Neurol. 2016;31:7&#x2013;19. doi: 10.11138/FNeur/2016.31.1.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.11138/FNeur/2016.31.1.007</ArticleId><ArticleId IdType="pmc">PMC4819821</ArticleId><ArticleId IdType="pubmed">27027889</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Cao C., Qin X.Y., Yu Y., Yuan J., Zhao Y., Cheng Y. Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: A meta-analysis study. Sci. Rep. 2017;7:12&#x2013;15. doi: 10.1038/s41598-017-09097-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09097-1</ArticleId><ArticleId IdType="pmc">PMC5567306</ArticleId><ArticleId IdType="pubmed">28831083</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xec; M.T., D&#x2019;Ambrosi N., Cozzolino M. Pathways to mitochondrial dysfunction in ALS pathogenesis. Biochem. Biophys. Res. Commun. 2017;483:1187&#x2013;1193. doi: 10.1016/j.bbrc.2016.07.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.07.055</ArticleId><ArticleId IdType="pubmed">27416757</ArticleId></ArticleIdList></Reference><Reference><Citation>Groen E.J.N., Pasterkamp R.J., van den Berg L.H., Koppers M., Blokhuis A.M. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:777&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasana E., Fossati M., Ruggiano A., Brambillasca S., Hoogenraad C.C., Navone F., Francolini M., Borgese N. A VAPB mutant linked to amyotrophic lateral sclerosis generates a novel form of organized smooth endoplasmic reticulum. FASEB J. 2010;24:1419&#x2013;1430. doi: 10.1096/fj.09-147850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.09-147850</ArticleId><ArticleId IdType="pubmed">20008544</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitne-Neto M., Machado-Costa M., Marchetto M.C.N., Bengtson M.H., Joazeiro C.A., Tsuda H., Bellen H.J., Silva H.C.A., Oliveira A.S.B., Lazar M., et al. Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum. Mol. Genet. 2011;20:3642&#x2013;3652. doi: 10.1093/hmg/ddr284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr284</ArticleId><ArticleId IdType="pmc">PMC3159551</ArticleId><ArticleId IdType="pubmed">21685205</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuling E., Ahmed S., Haasdijk E., Demmers J., Steinmetz M.O., Akhmanova A., Jaarsma D., Hoogenraad C.C. Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J. Neurosci. 2007;27:9801&#x2013;9815. doi: 10.1523/JNEUROSCI.2661-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2661-07.2007</ArticleId><ArticleId IdType="pmc">PMC6672975</ArticleId><ArticleId IdType="pubmed">17804640</ArticleId></ArticleIdList></Reference><Reference><Citation>Lev S., Halevy D.B., Peretti D., Dahan N. The VAP protein family: From cellular functions to motor neuron disease. Trends Cell Biol. 2008;18:282&#x2013;290. doi: 10.1016/j.tcb.2008.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2008.03.006</ArticleId><ArticleId IdType="pubmed">18468439</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Leal S.S., Ben Halevy D., Gomes C.M., Lev S. Structural requirements for VAP-B oligomerization and their implication in amyotrophic lateral sclerosis-associated VAP-B(P56S) neurotoxicity. J. Biol. Chem. 2010;285:13839&#x2013;13849. doi: 10.1074/jbc.M109.097345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.097345</ArticleId><ArticleId IdType="pmc">PMC2859547</ArticleId><ArticleId IdType="pubmed">20207736</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkogkas C., Middleton S., Kremer A.M., Wardrope C., Hannah M., Gillingwater T.H., Skehel P. VAPB interacts with and modulates the activity of ATF6. Hum. Mol. Genet. 2008;17:1517&#x2013;1526. doi: 10.1093/hmg/ddn040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn040</ArticleId><ArticleId IdType="pubmed">18263603</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf3;rotz G.M., De Vos K.J., Vagnoni A., Ackerley S., Shaw C.E., Miller C.C.J. Amyotrophic lateral sclerosis-associated mutant VAPBP56s perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Hum. Mol. Genet. 2012;21:1979&#x2013;1988. doi: 10.1093/hmg/dds011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds011</ArticleId><ArticleId IdType="pmc">PMC3315205</ArticleId><ArticleId IdType="pubmed">22258555</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H., Kanekura K., Levine T.P., Kohno K., Olkkonen V.M., Aiso S., Matsuoka M. ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB. J. Neurochem. 2009;108:973&#x2013;985. doi: 10.1111/j.1471-4159.2008.05857.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05857.x</ArticleId><ArticleId IdType="pubmed">19183264</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A.L., Mitne-Neto M., Silva H.C.A., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R.M., Gillingwater T., Webb J., et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 2004;75:822&#x2013;831. doi: 10.1086/425287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/425287</ArticleId><ArticleId IdType="pmc">PMC1182111</ArticleId><ArticleId IdType="pubmed">15372378</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques V.D., Barreira A.A., Davis M.B., Abou-Sleiman P.M., Silva W.A., Zago M.A., Sobreira C., Fazan V., Marques W. Expanding the phenotypes of the Pro56Ser VAPB mutation: Proximal SMA with dysautonomia. Muscle Nerve. 2006;34:731&#x2013;739. doi: 10.1002/mus.20657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20657</ArticleId><ArticleId IdType="pubmed">16967488</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.-J., Anagnostou G., Chai A., Withers J., Morris A., Adhikaree J., Pennetta G., de Belleroche J.S. Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. J. Biol. Chem. 2010;285:40266&#x2013;40281. doi: 10.1074/jbc.M110.161398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.161398</ArticleId><ArticleId IdType="pmc">PMC3001007</ArticleId><ArticleId IdType="pubmed">20940299</ArticleId></ArticleIdList></Reference><Reference><Citation>Anagnostou G., Paul P., Akbar M.T., Steiner T.J., Angelinetta C., de Belleroche J. Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord. Neurobiol. Aging. 2010;31:969&#x2013;985. doi: 10.1016/j.neurobiolaging.2008.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2008.07.005</ArticleId><ArticleId IdType="pubmed">18701194</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu L., Qiao T., Beers M., Tan W., Wang H., Yang B., Xu Z. Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice. Mol. Neurodegener. 2013;8:1. doi: 10.1186/1750-1326-8-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-1</ArticleId><ArticleId IdType="pmc">PMC3538568</ArticleId><ArticleId IdType="pubmed">23281774</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudor E.L., Galtrey C.M., Perkinton M.S., Lau K.-F., De Vos K.J., Mitchell J.C., Ackerley S., Hortob&#xe1;gyi T., V&#xe1;mos E., Leigh P.N., et al. Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. Neuroscience. 2010;167:774&#x2013;785. doi: 10.1016/j.neuroscience.2010.02.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.02.035</ArticleId><ArticleId IdType="pubmed">20188146</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M., van Es M.A., Koppers M., van Rheenen W., Medic J., Schelhaas H.J., van der Kooi A.J., de Visser M., Veldink J.H., van den Berg L.H. VAPB and C9orf72 mutations in 1 familial amyotrophic lateral sclerosis patient. Neurobiol. Aging. 2012;33:2950-e1. doi: 10.1016/j.neurobiolaging.2012.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.07.004</ArticleId><ArticleId IdType="pubmed">22878164</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew C.C., Ma J., Tang H.C., Zheng R., Dempsey A.A. The peripheral blood transcriptome dynamically reflects system wide biology: A potential diagnostic tool. J. Lab. Clin. Med. 2006;147:126&#x2013;132. doi: 10.1016/j.lab.2005.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lab.2005.10.005</ArticleId><ArticleId IdType="pubmed">16503242</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereda C., Leoni E., Milani P., Pansarasa O., Mazzini G., Guareschi S., Alvisi E., Ghiroldi A., Diamanti L., Bernuzzi S., et al. Altered Intracellular Localization of SOD1 in Leukocytes from Patients with Sporadic Amyotrophic Lateral Sclerosis. PLoS ONE. 2013;8:e75916. doi: 10.1371/journal.pone.0075916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0075916</ArticleId><ArticleId IdType="pmc">PMC3796534</ArticleId><ArticleId IdType="pubmed">24155874</ArticleId></ArticleIdList></Reference><Reference><Citation>Deidda I., Galizzi G., Passantino R., Cascio C., Russo D., Colletti T., La Bella V., Guarneri P. Expression of vesicle-associated membrane-protein-associated protein B cleavage products in peripheral blood leukocytes and cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Eur. J. Neurol. 2014;21:478&#x2013;485. doi: 10.1111/ene.12334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12334</ArticleId><ArticleId IdType="pubmed">24372953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G., Pozzi S., Pignataro M., Lauranzano E., Spano G., Garbelli S., Mantovani S., Marinou K., Papetti L., Monteforte M., et al. Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells. PLoS ONE. 2011;6:e25545. doi: 10.1371/journal.pone.0025545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025545</ArticleId><ArticleId IdType="pmc">PMC3187793</ArticleId><ArticleId IdType="pubmed">21998667</ArticleId></ArticleIdList></Reference><Reference><Citation>Silani V., Ludolph A., Fornai F. The emerging picture of ALS: A multisystem, not only a &#x201c;motor neuron disease&#x201d;. Arch. Ital. Biol. 2017;155:153&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">29405027</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar U.G., Milla V., Stafford M.Y.C., Bjourson A.J., Duddy W., Duguez S.M.R. A systematic review of suggested molecular strata, biomarkers and their tissue sources in ALS. Front. Neurol. 2019;10:400. doi: 10.3389/fneur.2019.00400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00400</ArticleId><ArticleId IdType="pmc">PMC6527847</ArticleId><ArticleId IdType="pubmed">31139131</ArticleId></ArticleIdList></Reference><Reference><Citation>Musar&#xf2; A. Understanding ALS: New therapeutic approaches. FEBS J. 2013;280:4315&#x2013;4322. doi: 10.1111/febs.12087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12087</ArticleId><ArticleId IdType="pubmed">23217177</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachreiner T., Esser M., Tenten V., Troost D., Weis J., Kr&#xfc;ttgen A. Novel splice variants of the amyotrophic lateral sclerosis-associated gene VAPB expressed in human tissues. Biochem. Biophys. Res. Commun. 2010;394:703&#x2013;708. doi: 10.1016/j.bbrc.2010.03.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2010.03.055</ArticleId><ArticleId IdType="pubmed">20227395</ArticleId></ArticleIdList></Reference><Reference><Citation>Jesse C.M., Bushuven E., Tripathi P., Chandrasekar A., Simon C.M., Drepper C., Yamoah A., Dreser A., Katona I., Johann S., et al. ALS-Associated Endoplasmic Reticulum Proteins in Denervated Skeletal Muscle: Implications for Motor Neuron Disease Pathology. Brain Pathol. 2017;27:781&#x2013;794. doi: 10.1111/bpa.12453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12453</ArticleId><ArticleId IdType="pubmed">27790792</ArticleId></ArticleIdList></Reference><Reference><Citation>Funke A.D., Esser M., Kr&#xfc;ttgen A., Weis J., Mitne-Neto M., Lazar M., Nishimura A.L., Sperfeld A.D., Trillenberg P., Senderek J., et al. The p.P56S mutation in the VAPB gene is not due to a single founder: The first European case. Clin. Genet. 2010;77:302&#x2013;303. doi: 10.1111/j.1399-0004.2009.01319.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2009.01319.x</ArticleId><ArticleId IdType="pmc">PMC2847198</ArticleId><ArticleId IdType="pubmed">20447143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J., Coulouris G., Zaretskaya I., Cutcutache I., Rozen S., Madden T.L. Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinf. 2012;13:134. doi: 10.1186/1471-2105-13-134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-13-134</ArticleId><ArticleId IdType="pmc">PMC3412702</ArticleId><ArticleId IdType="pubmed">22708584</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer B.F., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Papiani G., Ruggiano A., Fossati M., Raimondi A., Bertoni G., Francolini M., Benfante R., Navone F., Borgese N. Restructured endoplasmic reticulum generated by mutant amyotrophic lateral sclerosis-linked VAPB is cleared by the proteasome. J. Cell Sci. 2012;125:3601&#x2013;3611. doi: 10.1242/jcs.102137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.102137</ArticleId><ArticleId IdType="pubmed">22611258</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiriyama Y., Nochi H. The Function of Autophagy in Neurodegenerative Diseases. Int. J. Mol. Sci. 2015;16:26797&#x2013;26812. doi: 10.3390/ijms161125990.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms161125990</ArticleId><ArticleId IdType="pmc">PMC4661849</ArticleId><ArticleId IdType="pubmed">26569220</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciechanover A., Brundin P. The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg. Neuron. 2003;40:427&#x2013;446. doi: 10.1016/S0896-6273(03)00606-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(03)00606-8</ArticleId><ArticleId IdType="pubmed">14556719</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaronen M., Goidsteins G., Koistinaho J. ER stress and unfolded protein response in amyotrophic lateral sclerosis&#x2014;A controversial role of protein disulphide isomerase. Front. Cell. Neurosci. 2014;8:402. doi: 10.3389/fncel.2014.00402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00402</ArticleId><ArticleId IdType="pmc">PMC4251436</ArticleId><ArticleId IdType="pubmed">25520620</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Wey S., Zhang Y., Ye R., Lee A.S. Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. Antioxid. Redox Signal. 2009;11:2307&#x2013;2316. doi: 10.1089/ars.2009.2485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2485</ArticleId><ArticleId IdType="pmc">PMC2819800</ArticleId><ArticleId IdType="pubmed">19309259</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarti A., Chen A.W., Varner J.D. A review of the mammalian unfolded protein response. Biotechnol. Bioeng. 2011;108:2777&#x2013;2793. doi: 10.1002/bit.23282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bit.23282</ArticleId><ArticleId IdType="pmc">PMC3193940</ArticleId><ArticleId IdType="pubmed">21809331</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanida I., Ueno T., Kominami E. LC3 and autophagy. Methods Mol. Biol. 2008;445:77&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">18425443</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky N.B., Todd P.K., Taylor J.P. Autophagy and the ubiquitin-proteasome system: Collaborators in neuroprotection. Biochim. Biophys. Acta Mol. Basis Dis. 2008;1782:691&#x2013;699. doi: 10.1016/j.bbadis.2008.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2008.10.002</ArticleId><ArticleId IdType="pmc">PMC2621359</ArticleId><ArticleId IdType="pubmed">18930136</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xe9;gal L., Vanopdenbosch L., Tilkin P., Van Den Bosch L., Thijs V., Sciot R., Robberecht W. The G93C mutation in superoxide dismutase 1: Clinicopathologic phenotype and prognosis. Arch. Neurol. 2006;63:262&#x2013;267. doi: 10.1001/archneur.63.2.262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.63.2.262</ArticleId><ArticleId IdType="pubmed">16476815</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle K.M., Kennedy D., Gorman A.M., Gupta S., Healy S.J.M., Samali A. Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. J. Cell. Mol. Med. 2011;15:2025&#x2013;2039. doi: 10.1111/j.1582-4934.2011.01374.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1582-4934.2011.01374.x</ArticleId><ArticleId IdType="pmc">PMC4394214</ArticleId><ArticleId IdType="pubmed">21722302</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt M.F., Martinez F.J., Wright S., Ramos C., Volfson D., Mason M., Garnes J., Dang V., Lievers J., Shoukat-Mumtaz U., et al. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol. Cell. Neurosci. 2013;56:355&#x2013;364. doi: 10.1016/j.mcn.2013.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2013.07.007</ArticleId><ArticleId IdType="pmc">PMC4772428</ArticleId><ArticleId IdType="pubmed">23891805</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkogkas C., Wardrope C., Hannah M., Skehel P. The ALS8-associated mutant VAPBP56S is resistant to proteolysis in neurons. J. Neurochem. 2011;117:286&#x2013;294. doi: 10.1111/j.1471-4159.2011.07201.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07201.x</ArticleId><ArticleId IdType="pubmed">21275991</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr&#xf9; S., Manolakos E., Orr&#xf9; N., Kokotas H., Mascia V., Carcassi C., Petersen M. High frequency of the TARDBP p.Ala382Thr mutation in Sardinian patients with amyotrophic lateral sclerosis. Clin. Genet. 2012;81:172&#x2013;178. doi: 10.1111/j.1399-0004.2011.01668.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2011.01668.x</ArticleId><ArticleId IdType="pubmed">21418058</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M., Conforti F.L., Zollino M., Mora G., Monsurr&#xf2; M.R., Volanti P., Marinou K., Salvi F., Corbo M., Giannini F., et al. C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiol. Aging. 2012;33:1848&#x2013;e15. doi: 10.1016/j.neurobiolaging.2012.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.02.011</ArticleId><ArticleId IdType="pmc">PMC3372681</ArticleId><ArticleId IdType="pubmed">22418734</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliaga L., Lai C., Yu J., Chub N., Shim H., Sun L., Xie C., Yang W.J., Lin X., O&#x2019;Donovan M.J., et al. Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons. Hum. Mol. Genet. 2013;22:4293&#x2013;4305. doi: 10.1093/hmg/ddt279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt279</ArticleId><ArticleId IdType="pmc">PMC3792689</ArticleId><ArticleId IdType="pubmed">23771029</ArticleId></ArticleIdList></Reference><Reference><Citation>Prause J., Goswami A., Katona I., Roos A., Schnizler M., Bushuven E., Dreier A., Buchkremer S., Johann S., Beyer C., et al. Altered localization, abnormal modification and loss of function of sigma receptor-1 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;22:1581&#x2013;1600. doi: 10.1093/hmg/ddt008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt008</ArticleId><ArticleId IdType="pubmed">23314020</ArticleId></ArticleIdList></Reference><Reference><Citation>Masala A., Sanna S., Esposito S., Rassu M., Galioto M., Zinellu A., Carru C., Carr&#xec; M.T., Iaccarino C., Crosio C. Epigenetic Changes Associated with the Expression of Amyotrophic Lateral Sclerosis (ALS) Causing Genes. Neuroscience. 2018;390:1&#x2013;11. doi: 10.1016/j.neuroscience.2018.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.08.009</ArticleId><ArticleId IdType="pubmed">30134203</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>